Cairo – Mubasher: The Egyptian pharmaceutical distributor Ibnsina Pharma achieved a growth of 54% in profits during fiscal year 2018 compared to the prior year.
Earnings soared to EGP 262.52 million in FY18 from EGP 170.13 million in FY17, according to a bourse disclosure on Thursday.
Ibnsina Pharma has posted a revenue of EGP 13.6 billion from January to December 2018 compared to EGP 9.8 billion in FY17.
